Table 1 Association of the IGHV4-61*02 allele with RHD susceptibility by ancestry and country.

From: Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania

Grouping

Population

Subpopn

Subgroup

Cases

Controls

Effective

Minor allele freq.

Method

λ

OR (95% CI)

P

    

N

N

N

Cases

Controls

    

Ancestry

Melanesian

All

All

607

1229

1625

0.31

0.26

LMM

1.06

1.37 (1.19–1.57)

1.2 × 10 5

  

iTaukei

All

307

553

790

0.32

0.24

LMM

1.02

1.34 (1.07–1.67)

0.011

   

Matched

296

296

592

0.32

0.25

LMM

1.01

1.49 (1.15–1.94)

0.003

         

LR

1.01

1.51 (1.15–1.98)

0.0024

  

Kanak

All

280

154

397

0.31

0.22

LMM

1.03

1.80 (1.30–2.49)

0.00039

   

Matched

153

153

306

0.29

0.19

LMM

1.09

1.77 (1.22–2.58)

0.0028

         

LR

1.07

1.80 (1.21–2.69)

0.0028

 

Polynesian

All

All

160

233

379

0.27

0.21

LMM

1.02

1.53 (1.12–2.10)

0.0072

  

Samoan

All

61

74

134

0.32

0.18

LMM

0.99

2.07 (1.23–3.50)

0.0062

   

Matched

55

55

110

0.35

0.18

LMM

0.99

2.16 (1.25–3.75)

0.0061

         

LR

1.04

2.24 (1.21–4.15)

0.0066

 

Fijian Indian

All

All

168

151

318

0.18

0.12

LMM

1

1.91 (1.18–3.10)

0.0082

  

All

Matched

142

142

284

0.18

0.11

LMM

1

1.99 (1.18–3.36)

0.0096

         

LR

1.00

2.02 (1.18–3.49)

0.0092

 

Mixed and other

All

All

71

236

218

0.26

0.17

LMM

1.02

1.54 (0.97–2.46)

0.069

Country

Fiji Islands

All

All

532

751

1245

0.27

0.22

LMM

1.02

1.39 (1.16–1.67)

0.00043

 

New Caledonia

All

All

422

362

779

0.28

0.18

LMM

1.02

1.57 (1.25–1.97)

8.6 × 10−5

 

Samoa

All

All

61

75

135

0.32

0.18

LMM

0.99

2.10 (1.25–3.54)

0.0054

  1. CI, confidence interval; freq., frequency; LMM, linear mixed model; LR, logistic regression; OR, odds ratio; RHD, rheumatic heart disease; Subpopn, subpopulation.
  2. Lines highlighted in bold refer to the initial discovery and replication analyses, while other lines refer to subsequent sensitivity analyses. The genomic control factor (λ) was calculated from a genome-wide analysis using the analytical method indicated.